Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 124 citing articles:

InstaDock: A single-click graphical user interface for molecular docking-based virtual high-throughput screening
Taj Mohammad, Yash Mathur, Md. Imtaiyaz Hassan
Briefings in Bioinformatics (2020) Vol. 22, Iss. 4
Closed Access | Times Cited: 208
Investigation of inhibitory potential of quercetin to the pyruvate dehydrogenase kinase 3: Towards implications in anticancer therapy
Rashmi Dahiya, Taj Mohammad, Sonam Roy, et al.
International Journal of Biological Macromolecules (2019) Vol. 136, pp. 1076-1085
Closed Access | Times Cited: 95
MARK4 Inhibited by AChE Inhibitors, Donepezil and Rivastigmine Tartrate: Insights into Alzheimer’s Disease Therapy
Anas Shamsi, Saleha Anwar, Taj Mohammad, et al.
Biomolecules (2020) Vol. 10, Iss. 5, pp. 789-789
Open Access | Times Cited: 95
Discovery of Hordenine as a Potential Inhibitor of Pyruvate Dehydrogenase Kinase 3: Implication in Lung Cancer Therapy
Saleha Anwar, Taj Mohammad, Anas Shamsi, et al.
Biomedicines (2020) Vol. 8, Iss. 5, pp. 119-119
Open Access | Times Cited: 86
Identification of natural compounds as potent inhibitors of SARS-CoV-2 main protease using combined docking and molecular dynamics simulations
Deeba Shamim Jairajpuri, Afzal Hussain, Khalida Nasreen, et al.
Saudi Journal of Biological Sciences (2021) Vol. 28, Iss. 4, pp. 2423-2431
Open Access | Times Cited: 69
SGK1 in Human Cancer: Emerging Roles and Mechanisms
Yiwen Sang, Piaoping Kong, Shizhen Zhang, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 64
Potential Therapeutic Implications of Caffeic Acid in Cancer Signaling: Past, Present, and Future
Manzar Alam, Ghulam Md Ashraf, Kayenat Sheikh, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 41
Recent advances in the area of plant-based anti-cancer drug discovery using computational approaches
Agneesh Pratim Das, Subhash Mohan Agarwal
Molecular Diversity (2023) Vol. 28, Iss. 2, pp. 901-925
Open Access | Times Cited: 25
Identification of potential inhibitors of SARS-COV-2 endoribonuclease (EndoU) from FDA approved drugs: a drug repurposing approach to find therapeutics for COVID-19
Anshuman Chandra, Vaishali Gurjar, Imteyaz Qamar, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 39, Iss. 12, pp. 4201-4211
Open Access | Times Cited: 65
Identification of Sphingosine Kinase-1 Inhibitors from Bioactive Natural Products Targeting Cancer Therapy
Deeba Shamim Jairajpuri, Taj Mohammad, Kirtika Adhikari, et al.
ACS Omega (2020) Vol. 5, Iss. 24, pp. 14720-14729
Open Access | Times Cited: 49
Investigating neuroprotective roles of Bacopa monnieri extracts: Mechanistic insights and therapeutic implications
Urooj Fatima, Sonam Roy, Shahnawaz Ahmad, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113469-113469
Closed Access | Times Cited: 34
Therapeutic implications and clinical manifestations of thymoquinone
Manzar Alam, Gulam Mustafa Hasan, Md. Meraj Ansari, et al.
Phytochemistry (2022) Vol. 200, pp. 113213-113213
Closed Access | Times Cited: 30
Structure restoration and aggregate inhibition of V30M mutant transthyretin protein by potential quinoline molecules
Sachin Kumar, Vijay Kumar Bhardwaj, Rahul Singh, et al.
International Journal of Biological Macromolecules (2023) Vol. 231, pp. 123318-123318
Closed Access | Times Cited: 18
PF543-like compound, a promising sphingosine kinase 1 inhibitor: Structure-based virtual screening and molecular dynamic simulation approaches
Moyad Shahwan, Nageeb Hassan, Akram Ashames, et al.
International Journal of Biological Macromolecules (2023) Vol. 245, pp. 125466-125466
Closed Access | Times Cited: 16
Identifying potential inhibitors of phosphatidylinositol 4,5-bisphosphate 3-kinase: Molecular dynamic insights into the interaction and inhibitory mechanism
Taj Mohammad, Afzal Hussain, Mohamed F. Alajmi, et al.
Chemical Physics Impact (2024) Vol. 8, pp. 100458-100458
Open Access | Times Cited: 5
Targeting PDE4A for therapeutic potential: exploiting drug repurposing approach through virtual screening and molecular dynamics
Anas Shamsi, Mohd Shahnawaz Khan, Nojood Altwaijry, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-13
Closed Access | Times Cited: 5
Targeting prostate cancer via therapeutic targeting of PIM-1 kinase by Naringenin and Quercetin
Aanchal Rathi, Arunabh Chaudhury, Farah Anjum, et al.
International Journal of Biological Macromolecules (2024) Vol. 276, pp. 133882-133882
Closed Access | Times Cited: 5
Virtual screening and molecular dynamics simulations identify repurposed drugs as potent inhibitors of Histone deacetylase 1: Implication in cancer therapeutics
Mohammed Alrouji, Kumar Venkatesan, Mohammed S. Alshammari, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0316343-e0316343
Open Access
Phytochemicals Withanolide N and Dryobalanolide as Potential Bioactive Leads for Developing Anticancer Drugs Targeting Tyrosine-Protein Kinase Mer
Afzal Hussain, Taj Mohammad, Mehak Gulzar, et al.
OMICS A Journal of Integrative Biology (2025)
Closed Access
Insights into SARS-CoV-2 structure: Approaches and action of SARS-CoV-2 main protease inhibitor
Ilma Shakeel, Aaliya Taiyab, Aanchal Rathi, et al.
Elsevier eBooks (2025), pp. 89-117
Closed Access
Apigenin-mediated MARK4 inhibition: a novel approach in advancing Alzheimer’s disease therapeutics
Afzal Hussain, Deeba Shamim Jairajpuri, Saleha Anwar, et al.
Molecular Diversity (2025)
Closed Access
Therapeutic Targeting of Interleukin-2-Inducible T-Cell Kinase (ITK) for Cancer and Immunological Disorders: Potential Next-Generation ITK Inhibitors
Sayeed Ahmed, Mohammad Umar Saeed, Arunabh Choudhury, et al.
OMICS A Journal of Integrative Biology (2025) Vol. 29, Iss. 3, pp. 105-115
Closed Access
Shape-based Machine Learning Models for the Potential Novel COVID-19 Protease Inhibitors Assisted by Molecular Dynamics Simulation
Anuraj Nayarisseri, Ravina Khandelwal, Maddala Madhavi, et al.
Current Topics in Medicinal Chemistry (2020) Vol. 20, Iss. 24, pp. 2146-2167
Closed Access | Times Cited: 41
Structural and biochemical investigation of MARK4 inhibitory potential of cholic acid: Towards therapeutic implications in neurodegenerative diseases
Saleha Anwar, Anas Shamsi, Rajiv K. Kar, et al.
International Journal of Biological Macromolecules (2020) Vol. 161, pp. 596-604
Closed Access | Times Cited: 40
Identification of plant-based hexokinase 2 inhibitors: combined molecular docking and dynamics simulation studies
Asifa Khan, Taj Mohammad, Anas Shamsi, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 20, pp. 10319-10331
Closed Access | Times Cited: 36
Page 1 - Next Page

Scroll to top